The incidence of portal vein thrombosis at liver transplantation
- PMID: 1427658
- PMCID: PMC2989675
The incidence of portal vein thrombosis at liver transplantation
Abstract
The incidence of portal vein thrombosis was examined in 885 patients who received orthotopic liver transplantations for various end-stage liver diseases between 1989 and 1990. The thrombosis was classified into four grades. Grade 1 was thrombosis of intrahepatic portal vein branches, grade 2 was thrombosis of the right or left portal branch or at the bifurcation, grade 3 was partial obstruction of the portal vein trunk, and grade 4 was complete obstruction of the portal vein trunk. Among the 849 patients without previous portosystemic shunt, 14 patients (1.6%) had grade 1, 27 patients (3.2%) had grade 2, 27 patients (3.2%) had grade 3 and 49 patients (5.8%) had grade 4 portal vein thrombosis. The incidence of portal vein thrombosis was highest (34.8%) in the patients with hepatic malignancy in the cirrhotic liver, followed by those with Budd-Chiari syndrome (22.2%) and postnecrotic cirrhosis of various causes (15.7%). The patients with encephalopathy, ascites, variceal bleeding, previous splenectomy and small liver had significantly higher incidences of portal vein thrombosis than the others. The total incidence of portal vein thrombosis among the 36 patients with previous portosystemic shunt was 38.9%, which was significantly higher than that (13.8%) of those without shunt.
Similar articles
-
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.Aliment Pharmacol Ther. 2006 Mar 15;23(6):767-75. doi: 10.1111/j.1365-2036.2006.02820.x. Aliment Pharmacol Ther. 2006. PMID: 16556179
-
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.Liver Int. 2016 May;36(5):667-76. doi: 10.1111/liv.12929. Epub 2015 Aug 28. Liver Int. 2016. PMID: 26235541
-
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.Med Sci Monit. 2012 Aug;18(8):HY37-41. doi: 10.12659/msm.883252. Med Sci Monit. 2012. PMID: 22847208 Free PMC article.
-
[Splanchnic vein thrombosis].Rev Med Interne. 2024 Jan;45(1):17-25. doi: 10.1016/j.revmed.2023.07.005. Epub 2023 Oct 12. Rev Med Interne. 2024. PMID: 37838484 Review. French.
-
[Portosystemic shunt surgery between TIPS and liver transplantation].Chirurg. 2011 Oct;82(10):898-905. doi: 10.1007/s00104-011-2100-1. Chirurg. 2011. PMID: 21932152 Review. German.
Cited by
-
Coagulation, Microenvironment and Liver Fibrosis.Cells. 2018 Jul 24;7(8):85. doi: 10.3390/cells7080085. Cells. 2018. PMID: 30042349 Free PMC article. Review.
-
Portal vein thrombosis in liver cirrhosis.World J Hepatol. 2014 Feb 27;6(2):64-71. doi: 10.4254/wjh.v6.i2.64. World J Hepatol. 2014. PMID: 24575165 Free PMC article. Review.
-
Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.Dig Dis Sci. 2023 Aug;68(8):3458-3466. doi: 10.1007/s10620-023-07993-3. Epub 2023 Jun 22. Dig Dis Sci. 2023. PMID: 37349605
-
Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment.J Clin Med. 2021 May 26;10(11):2316. doi: 10.3390/jcm10112316. J Clin Med. 2021. PMID: 34073236 Free PMC article.
-
Improving survival in decompensated cirrhosis.Int J Hepatol. 2012;2012:318627. doi: 10.1155/2012/318627. Epub 2012 Jul 2. Int J Hepatol. 2012. PMID: 22811919 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical